Clone ID | DMC463 |
---|---|
Target | |
Synonyms | TF; Coagulation factor III; F3 |
Host Species | Rabbit |
Description | Anti-CD142 antibody(DMC463); IgG1 Chimeric mAb |
Delivery | In Stock |
Uniprot ID | P13726 |
IgG type | Rabbit/Human Fc chimeric IgG1 |
Clonality | Monoclonal |
Reactivity | Human |
Applications | Flow Cyt |
Recommended Dilutions | Flow Cyt 1:100 |
Purification | Purified from cell culture supernatant by affinity chromatography |
Formulation & Reconstitution | Lyophilized from sterile PBS, pH 7.4. Normally 5 % – 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution. |
Storage & Shipping | Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature. |
Background | This gene encodes coagulation factor III which is a cell surface glycoprotein. This factor enables cells to initiate the blood coagulation cascades; and it functions as the high-affinity receptor for the coagulation factor VII. The resulting complex provides a catalytic event that is responsible for initiation of the coagulation protease cascades by specific limited proteolysis. Unlike the other cofactors of these protease cascades; which circulate as nonfunctional precursors; this factor is a potent initiator that is fully functional when expressed on cell surfaces; for example; on monocytes. There are 3 distinct domains of this factor: extracellular; transmembrane; and cytoplasmic. Platelets and monocytes have been shown to express this coagulation factor under procoagulatory and proinflammatory stimuli; and a major role in HIV-associated coagulopathy has been described. Platelet-dependent monocyte expression of coagulation factor III has been described to be associated with Coronavirus Disease 2019 (COVID-19) severity and mortality. This protein is the only one in the coagulation pathway for which a congenital deficiency has not been described. Alternate splicing results in multiple transcript variants.[provided by RefSeq; Aug 2020] |
Usage | Research use only |
Conjugate | Unconjugated |
Anti-CD142 antibody(DMC463); IgG1 Chimeric mAb
Price: 10μg $99.00 ; 100 μg $446.00 ; 500 μg $1340.00
Product Data
Images
Figure 1. Flow cytometry analysis with Anti-CD142 (DMC463) on Expi293 cells transfected with human CD142 (Blue histogram) or Expi293 transfected with irrelevant protein (Red histogram).
Figure 2. Flow cytometry analysis of antigen binding of anti-human CD142 mAb(DMC100463).
(A) DMC100463 does not bind to CHO-S cells that do not express CD142.
(B) A clear peak shift of DMC100463 was seen compared to the control when incubated with CD142-expressing Hela cells, indicating strong binding of DMC100463 to CD142. Antibodies were incubated at 5 μg/mL.
Related Products
Biosimilar reference antibodies
SKU: BME100661 Target: CD142
Application: N/A
Price: 50μg $82.00 ; 100 μg $162.00
ECD Proteins
SKU: PME-C100079 Target: CD142
Price: 10μg $120.00 ; 50μg $450.00 ; 100μg $660.00
ECD Proteins
SKU: PME100751 Target: CD142
Price: 10μg $120.00 ; 50μg $450.00 ; 100 μg $660.00
DiSliceX
SKU: SLI100016 Target: AXL, CD142, CD63, CD73, CD99, HBEGF, LGALS1, NRG1, ROR1, TGFBR2, VEGFA
Application: IHC
Price: 2 slides $129.00
DiSliceX
SKU: SLI100005 Target: ADAM9, CD142, CD63, CDH1, CDH3, EGFR, GPR87, JAM-A, MICA, NECTIN4, PCSK, PSCA, Trop2
Application: IHC
Price: 2 slides $129.00